XYNOMIC PHARMACEUTICALS HOLDINGS, INC.
DelistedCIK 1697805fmd_1HDQJ69A6K9CK3G17W1HMEJPFZManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 02, 2016 to Dec 31, 2019, 13 periods
| Line item | FY2017 | FY2018 | FY2019 |
|---|---|---|---|
| Net interest income | – | – | 0 |
| Research and development | – | 25 | 12 |
| Total operating expenses | 0 | 29 | 25 |
| Operating income | (0) | (29) | (25) |
| Income before taxes | – | (29) | (25) |
| Net income | (0) | (29) | (25) |
| Net income to common shareholders | (0) | (31) | (27) |